drugset / Trial / NCT07387094

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

NCT07387094

Phase 3 Recruiting 140 enrolled Hangzhou Sciwind Biosciences Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA but not receiving PAP

Timeline

Start
2026-02-09
Primary completion
2027-12-16
Completion
2027-12-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Ecnoglutide Protein / enzyme biologic Subcutaneous